EditorialCreativeSportKollektionenVideos
Preise
0Anmelden

Visuelle Inhalte für Profis.
800 Mio.+ Bilder und Videos.

Content-Hub

  • Aktuelle Ereignisse
  • Bilder des Jahres
  • Sport
  • Editorial
  • Creative
  • Kollektionen
  • Videos

Angebote

  • Preise & Pakete
  • Aktionen
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Bildrecherche
  • Auftragsfotografie
  • API & FTP Push
  • my-picturemaxx
  • Partner werden

Unternehmen

  • Über IMAGO
  • Karriere
  • News

Hilfe-Center

  • FAQ
  • Kontakt
ImpressumNutzungsbedingungenLizenzinformationenDatenschutzDatenschutzeinstellungen
© 2026 IMAGO
CEPICBAPLABVPA
  5. Coronavirus: AstraZeneca hofft auf Impfstoffzulassung noch in 2020

Coronavirus: AstraZeneca hofft auf Impfstoffzulassung noch in 2020

25.08.2020

Die folgenden Fotos wurden von der IMAGO Bildredaktion zu diesem Thema für Sie ausgewählt. Für weitere Bilder nutzen Sie bitte die Suchfunktion.

Bilder in dieser Kollektion

  • ASTRAZENECA STOCK, A general view of analytical chemist?s at AstraZeneca?s headquarters in Sydney, Wednesday, August 19, 2020. Prime Minister Scott Morrison announced Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the government and UK-based drug company AstraZeneca. ( NO ARCHIVING, EDITORIAL USE ONLY, NO USE IN BOOKS WITHOUT CONSENT Sydney NSW AUSTRALIA Copyright: xDANxHIMBRECHTSx 20200819001485708630

    ASTRAZENECA STOCK, A general view of analytical chemist?s at AstraZeneca?s headquarters in Sydney, Wednesday, August 19, 2020. Prime Minister Scott Morrison announced Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the government and UK-based drug company AstraZeneca. ( NO ARCHIVING, EDITORIAL USE ONLY, NO USE IN BOOKS WITHOUT CONSENT Sydney NSW AUSTRALIA Copyright: xDANxHIMBRECHTSx 20200819001485708630

  • ASTRAZENECA STOCK, A general view of AstraZeneca?s headquarters in Sydney, Wednesday, August 19, 2020. Prime Minister Scott Morrison announced Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the government and UK-based drug company AstraZeneca. ( NO ARCHIVING, EDITORIAL USE ONLY, NO USE IN BOOKS WITHOUT CONSENT Sydney NSW AUSTRALIA Copyright: xDANxHIMBRECHTSx 20200819001485708584

    ASTRAZENECA STOCK, A general view of AstraZeneca?s headquarters in Sydney, Wednesday, August 19, 2020. Prime Minister Scott Morrison announced Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the government and UK-based drug company AstraZeneca. ( NO ARCHIVING, EDITORIAL USE ONLY, NO USE IN BOOKS WITHOUT CONSENT Sydney NSW AUSTRALIA Copyright: xDANxHIMBRECHTSx 20200819001485708584

  • Symbolbild eines Corona Impfstoffs mit Logo des Pharmaunternehmens AstraZeneca. Forschern der Universität Oxford scheint ein großer Schritt in Richtung Corona-Impfstoff gelungen zu sein.

    Symbolbild eines Corona Impfstoffs mit Logo des Pharmaunternehmens AstraZeneca. Forschern der Universität Oxford scheint ein großer Schritt in Richtung Corona-Impfstoff gelungen zu sein.

  • Symbolbild eines Corona Impfstoffs mit Logo des Pharmaunternehmens AstraZeneca. Forschern der Universität Oxford scheint ein großer Schritt in Richtung Corona-Impfstoff gelungen zu sein.

    Symbolbild eines Corona Impfstoffs mit Logo des Pharmaunternehmens AstraZeneca. Forschern der Universität Oxford scheint ein großer Schritt in Richtung Corona-Impfstoff gelungen zu sein.

  • NIJMEGEN: 18-06-2020, Company Astrazeneca in Nijmegen (The Netherlands), Astra Zeneca COVID-19: Company Astrazeneca in Nijmegen x8446244x Copyright:

    NIJMEGEN: 18-06-2020, Company Astrazeneca in Nijmegen (The Netherlands), Astra Zeneca COVID-19: Company Astrazeneca in Nijmegen x8446244x Copyright:

  • NIJMEGEN: 18-06-2020, Company Astrazeneca in Nijmegen (The Netherlands), Astra Zeneca COVID-19: Company Astrazeneca in Nijmegen x8446243x Copyright:

    NIJMEGEN: 18-06-2020, Company Astrazeneca in Nijmegen (The Netherlands), Astra Zeneca COVID-19: Company Astrazeneca in Nijmegen x8446243x Copyright:

  • (200519) -- BEIJING, May 19, 2020 -- Photo taken on May 18, 2020 shows a logo in front of AstraZeneca s building in Luton, Britain. The Oxford University has confirmed a global licensing agreement with AstraZeneca, which will make 30 million vaccine doses available to Britain by September if the trials are successful, as part of an agreement for 100 million doses in total, said British Secretary of State for Business, Energy and Industrial Strategy Alok Sharma. (Photo by Xinhua) XINHUA PHOTOS OF THE DAY TimxIreland

    (200519) -- BEIJING, May 19, 2020 -- Photo taken on May 18, 2020 shows a logo in front of AstraZeneca s building in Luton, Britain. The Oxford University has confirmed a global licensing agreement with AstraZeneca, which will make 30 million vaccine doses available to Britain by September if the trials are successful, as part of an agreement for 100 million doses in total, said British Secretary of State for Business, Energy and Industrial Strategy Alok Sharma. (Photo by Xinhua) XINHUA PHOTOS OF THE DAY TimxIreland

  • (200518) -- LUTON, May 18, 2020 (Xinhua) -- Photo taken on May 18, 2020 shows a logo in front of AstraZeneca s building in Luton, Britain. The Oxford University has confirmed a global licensing agreement with AstraZeneca, which will make 30 million vaccine doses available to Britain by September if the trials are successful, as part of an agreement for 100 million doses in total, said British Secretary of State for Business, Energy and Industrial Strategy Alok Sharma. (Photo by Tim Ireland Xinhua) BRITAIN-LUTON-COVID-19-VACCINE

    (200518) -- LUTON, May 18, 2020 (Xinhua) -- Photo taken on May 18, 2020 shows a logo in front of AstraZeneca s building in Luton, Britain. The Oxford University has confirmed a global licensing agreement with AstraZeneca, which will make 30 million vaccine doses available to Britain by September if the trials are successful, as part of an agreement for 100 million doses in total, said British Secretary of State for Business, Energy and Industrial Strategy Alok Sharma. (Photo by Tim Ireland Xinhua) BRITAIN-LUTON-COVID-19-VACCINE

  • ST PETERSBURG, RUSSIA – JUNE 7, 2019: AstraZeneca CEO Pascal Soriot at the 2019 St Petersburg International Economic Forum (SPIEF), at the ExpoForum Convention and Exhibition Centre. Anton Novoderezhkin TASS Host Photo Agency TS0AE59F

    ST PETERSBURG, RUSSIA – JUNE 7, 2019: AstraZeneca CEO Pascal Soriot at the 2019 St Petersburg International Economic Forum (SPIEF), at the ExpoForum Convention and Exhibition Centre. Anton Novoderezhkin TASS Host Photo Agency TS0AE59F

  • April 29, 2019 - GloRia De Dourados, Mato Grosso do Sul, Brazil - In this photo illustration the AstraZeneca PLC logo seen displayed on a smartphone. GloRia De Dourados Brazil - ZUMAs197 20190429_zab_s197_025 Copyright: xRafaelxHenriquex

    April 29, 2019 - GloRia De Dourados, Mato Grosso do Sul, Brazil - In this photo illustration the AstraZeneca PLC logo seen displayed on a smartphone. GloRia De Dourados Brazil - ZUMAs197 20190429_zab_s197_025 Copyright: xRafaelxHenriquex

  • February 26, 2019 - Washington, District of Columbia, U.S. - Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: CNP Washington U.S. - ZUMAs152 20190226_zaa_s152_044 Copyright: xChrisxKleponisx

    February 26, 2019 - Washington, District of Columbia, U.S. - Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: CNP Washington U.S. - ZUMAs152 20190226_zaa_s152_044 Copyright: xChrisxKleponisx

  • Pascal Soriot, executive director and CEO of AstraZeneca looks on during a Senate Finance Committee hearing on Drug Pricing in America on Capitol Hill in Washington, D.C. on February 26, 2019. WAP201902268029 ALEXxEDELMAN

    Pascal Soriot, executive director and CEO of AstraZeneca looks on during a Senate Finance Committee hearing on Drug Pricing in America on Capitol Hill in Washington, D.C. on February 26, 2019. WAP201902268029 ALEXxEDELMAN

Kollektionen
Auswahl